
KinoPharma
Developer of molecule drugs designed to provide antiviral medication to women for papillomavirus (HPV) infection. The company's research responds to the discovery and clinical development of next-gene...
Valuation
$0
Share Price
N/A
Total Raised
$29.9M
Last Round
N/A